The cerebellum, often referred to as the ‘little brain’, has captivated researchers for centuries due to its unique structure and cellular complexity, as one of the most ancient brain regions in evolutionary terms.
MindMed’s Phase 2b Trial For MM-120 in GAD Reaches Enrollment Milestone
MindMed (NASDAQ: MNMD) (NEO: MMED), a clinical-stage biopharmaceutical company focused on pioneering innovative treatments for brain health disorders, made a noteworthy announcement today. They have